Notice Title

Consent to the Distribution of New Medicines

Publication Date
12 Apr 2018

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2018-go1675
Title
View PDF
File Type and Size
PDF (35 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Component 1:

Active Ingredients:

Dosage Form:
Component 2:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturer:

Cold & Flu Day + Night PE

Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Tablet

Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Tablet
PSM Healthcare Limited trading as API Consumer Brands
PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Movantik
Naloxegol Oxalate 14.2mg equivalent to naloxegol 12.5mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Movantik
Naloxegol Oxalate 28.5mg equivalent to naloxegol 25mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden

Dated this 6th day of April 2018.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).